| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0306-4522(99)00059-7 |
| P698 | PubMed publication ID | 10336054 |
| P2093 | author name string | Holzer M | |
| Arendt T | |||
| Gärtner U | |||
| P2860 | cites work | Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type | Q53201609 |
| Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade | Q58112395 | ||
| Ras-signaling pathways: positive and negative regulation of tau expression in PC12 cells | Q74015471 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein | Q28256250 | ||
| Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein | Q28305440 | ||
| Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. | Q35616076 | ||
| Mitotic mechanisms in Alzheimer's disease? | Q36236501 | ||
| ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 cells | Q36530493 | ||
| The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease | Q38611694 | ||
| Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cells | Q41190133 | ||
| Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease | Q42477274 | ||
| Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrus | Q45089570 | ||
| Induction of basic Fibroblast Growth Factor in Alzheimerʼs disease pathology | Q46894345 | ||
| Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease | Q48139408 | ||
| Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease | Q48270749 | ||
| Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease | Q48320192 | ||
| Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. | Q48330754 | ||
| Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index | Q48482439 | ||
| Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. | Q48487273 | ||
| Hepatocyte growth factor (HGF/SF) in Alzheimer's disease | Q48528548 | ||
| Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway | Q48567917 | ||
| Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus | Q48591069 | ||
| Cell cycle markers in the hippocampus in Alzheimer's disease | Q48671520 | ||
| Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain | Q48706959 | ||
| Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions | Q48786969 | ||
| Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex | Q48879964 | ||
| Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. | Q53199479 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 1-5 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration | |
| P478 | volume | 91 |
| Q60045614 | 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease |
| Q53232860 | Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. |
| Q38857243 | Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease |
| Q39619549 | Activation of amyloid precursor protein processing by growth factors is dependent on Ras GTPase activity. |
| Q34286579 | AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease |
| Q35974525 | Alzheimer's disease as a disorder of dynamic brain self-organization |
| Q34142269 | Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization |
| Q35708114 | Alzheimer's disease: the two-hit hypothesis |
| Q57006022 | An allele of HRAS1 3'variable number of tandem repeats is a frailty allele: implication for an evolutionarily-conserved pathway involved in longevity |
| Q35793508 | BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease |
| Q33791646 | Biomarkers in Alzheimer's disease: past, present and future |
| Q54738945 | Cell cycle activation and CNS injury. |
| Q40120725 | Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products |
| Q37722680 | Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis |
| Q42508999 | Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease |
| Q42467173 | Constitutive Ras activity induces hippocampal hypertrophy and remodeling of pyramidal neurons in synRas mice |
| Q44085921 | Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex |
| Q27864126 | Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease |
| Q34241440 | Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease |
| Q35083375 | Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis |
| Q48435650 | ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion |
| Q39316007 | Exploring the biochemistry of the prenylome and its role in disease through proteomics: progress and potential. |
| Q42451752 | Expression of constitutively active p21H-rasval12 in postmitotic pyramidal neurons results in increased dendritic size and complexity. |
| Q53243973 | Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. |
| Q53350076 | Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. |
| Q54223105 | Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer's disease. |
| Q41328860 | Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology. |
| Q34574992 | Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment |
| Q37016092 | Natural antioxidants in Alzheimer's disease |
| Q34976296 | Neuroplasticity in Alzheimer's disease |
| Q91827638 | Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease |
| Q34070765 | Pathological implications of cell cycle re-entry in Alzheimer disease |
| Q44486768 | Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. |
| Q26858942 | Protein prenylation and synaptic plasticity: implications for Alzheimer's disease |
| Q42338638 | Retinoschisin is linked to retinal Na/K-ATPase signaling and localization |
| Q37671001 | Review: cell cycle aberrations and neurodegeneration |
| Q39242927 | SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells |
| Q47795955 | The identification and characterization of oxidized RNAs in Alzheimer's disease. |
| Q38094984 | The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD. |
| Q24292400 | Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc |
| Q47739695 | Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation |
| Q48407971 | Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease |
| Q30753189 | What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians |
Search more.